ID: ALA2377387

Max Phase: Preclinical

Molecular Formula: C20H25NO2S

Molecular Weight: 343.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CCSC(=O)C(O)(c1ccccc1)c1ccccc1

Standard InChI:  InChI=1S/C20H25NO2S/c1-3-21(4-2)15-16-24-19(22)20(23,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,23H,3-4,15-16H2,1-2H3

Standard InChI Key:  BEJYISOPDBBZRK-UHFFFAOYSA-N

Associated Targets(Human)

Muscarinic acetylcholine receptor M1 and M3 256 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M4 6041 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M3 7750 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M1 12690 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M2 10671 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 343.49Molecular Weight (Monoisotopic): 343.1606AlogP: 3.52#Rotatable Bonds: 8
Polar Surface Area: 40.54Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.40CX Basic pKa: 9.32CX LogP: 3.93CX LogD: 2.01
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.80Np Likeness Score: -0.68

References

1. Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK..  (2013)  Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,  21  (9): [PMID:23523385] [10.1016/j.bmc.2013.01.072]

Source